Relationship between haemagglutination inhibition titre and immunity to influenza in ferrets

Vaccine

Volumn 33, Issue 41, 2015, Pages 5380-5385

  Wikramaratna, Paul S ^a   Rambaut, Andrew ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Antigenic evolution; Ferrets; Haemagglutination inhibition assay; Influenza

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASSAY; CROSS PROTECTION; EXPERIMENTAL MODEL; HEMAGGLUTINATION INHIBITION; IMMUNITY; INFLUENZA; INFLUENZA VIRUS; NONHUMAN; PRIORITY JOURNAL; VIRUS STRAIN; ALGORITHM; ANIMAL; BIOLOGICAL MODEL; EVOLUTION; FERRET; HEMAGGLUTINATION; HEMAGGLUTINATION INHIBITION TEST; IMMUNOLOGY; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRUS INFECTION; STATISTICAL MODEL; VIROLOGY;

ALGORITHMS; ANIMALS; BIOLOGICAL EVOLUTION; FERRETS; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTINATION, VIRAL; IMMUNITY; MODELS, BIOLOGICAL; MODELS, STATISTICAL; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS;

EID: 84941879448     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.08.065     Document Type: Article

References (33)

1. Stephenson I., Das R.G., Wood J.M., Katz J.M. Comparison of neutralising antibody assays for detection of antibody to influenza A/H3N2 viruses: an international collaborative study. Vaccine 2007, 25:4056-4063. 10.1016/j.vaccine.2007.02.039.
2. Stephenson I., Heath A., Major D., Newman R.W., Hoschler K., Junzi W., et al. Reproducibility of serologic assays for influenza virus A (H5N1). Emerg Infect Dis 2009, 15:1252-1259. 10.3201/eid1508.081754.
3. Wood J.M., Major D., Heath A., Newman R.W., Höschler K., Stephenson I., et al. Reproducibility of serology assays for pandemic influenza H1N1: collaborative study to evaluate a candidate WHO International Standard. Vaccine 2012, 30:210-217. 10.1016/j.vaccine.2011.11.019.
4. Wikramaratna P.S., Sandeman M., Recker M., Gupta S. The antigenic evolution of influenza: drift or thrift?. Philos Trans R Soc Lond B Biol Sci 2013, 368:20120200. 10.1098/rstb.2012.0200.
5. Hensley S.E. Challenges of selecting seasonal influenza vaccine strains for humans with diverse pre-exposure histories. Curr Opin Virol 2014, 8:85-89. 10.1016/j.coviro.2014.07.007.
6. Li Y., Myers J.L., Bostick D.L., Sullivan C.B., Madara J., Linderman S.L., et al. Immune history shapes specificity of pandemic H1N1 influenza antibody responses. J Exp Med 2013, 210:1493-1500. 10.1084/jem.20130212.
7. Smith D.J., Lapedes A.S., de Jong J.C., Bestebroer T.M., Rimmelzwaan G.F., Osterhaus A.D.M.E., et al. Mapping the antigenic and genetic evolution of influenza virus. Science 2004, 305:371-376. 10.1126/science.1097211.
8. Bedford T., Suchard M.A., Lemey P., Dudas G., Gregory V., Hay A.J., et al. Integrating influenza antigenic dynamics with molecular evolution. Elife 2014, 3:e01914. 10.7554/eLife.01914.
9. Coudeville L., Bailleux F., Riche B., Megas F., Andre P., Ecochard R. Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a Bayesian random-effects model. BMC Med Res Methodol 2010, 10:18. 10.1186/1471-2288-10-18.
10. Hobson D., Curry R.L., Beare A.S., Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) 1972, 70:767-777.
11. Katz J.M., Hancock K., Xu X. Serologic assays for influenza surveillance, diagnosis and vaccine evaluation. Expert Rev Anti Infect Ther 2011, 9:669-683. 10.1586/eri.11.51.
12. Cauchemez S., Horby P., Fox A., Mai L.Q., Thanh L.T., Thai P.Q., et al. Influenza infection rates, measurement errors and the interpretation of paired serology. PLoS Pathog 2012, 8:e1003061. 10.1371/journal.ppat.1003061.
13. Potter C.W., Shore S.L., McLaren C., Stuart-Harris C. Immunity to influenza in ferrets. II. Influence of adjuvants on immunization. Br J Exp Pathol 1972, 53:168-179.
14. McLaren C., Potter C.W. Immunity to influenza in ferrets. 8. Serological response of ferrets to influenza virus vaccines after infection with heterotypic strains of influenza. Med Microbiol Immunol 1973, 159:53-62.
15. McLaren C., Potter C.W. Immunity to influenza in ferrets. VII. Effect of previous infection with heterotypic and heterologous influenza viruses on the response of ferrets to inactivated influenza virus vaccines. J Hyg (Lond) 1974, 72:91-100.
16. Potter C.W., McLaren C., Shore S.L. Immunity to influenza in ferrets. V. Immunization with inactivated virus in adjuvant 65. J Hyg (Lond) 1973, 71:97-106.
17. Potter C.W., Oxford J.S., Shore S.L., McLaren C., Stuart-Harris C. Immunity to influenza in ferrets. I. Response to live and killed virus. Br J Exp Pathol 1972, 53:153-167.
18. McLaren C., Potter C.W., Jennings R. Immunity to influenza in ferrets. X. Intranasal immunization of ferrets with inactivated influenza A virus vaccines. Infect Immun 1974, 9:985-990.
19. McLaren C., Potter C.W., Jennings R. Immunity to influenza in ferrets. 13. Protection against influenza infection by serum antibody to homologous haemagglutinin or neuraminidase antigens. Med Microbiol Immunol 1974, 160:33-45.
20. Dunning A.J. A model for immunological correlates of protection. Stat Med 2006, 25:1485-1497.
21. McLaren C., Potter C.W., Jennings R. Immunity to influenza in ferrets. XI. Cross-immunity between A/Hong Kong/68 and A/England/72 viruses: serum antibodies produced by infection or immunization. J Hyg (Lond) 1974, 73:389-399.
22. Plummer M. rjags: Bayesian graphical models using MCMC 2014.
23. Gelman A., Rubin D.B. Inference from iterative simulation using multiple sequences. Stat Sci 1992, 7:457-472.
24. Tsang T.K., Cauchemez S., Perera R.A.P.M., Freeman G., Fang V.J., Ip D.K.M., et al. Association between antibody titers and protection against influenza virus infection within households. J Infect Dis 2014, 10.1093/infdis/jiu186.
25. Roberts K.L., Shelton H., Stilwell P., Barclay W.S. Transmission of a 2009 H1N1 pandemic influenza virus occurs before fever is detected, in the ferret model. PLoS ONE 2012, 7:e43303. 10.1371/journal.pone.0043303.
26. Laurie K.L., Carolan L.A., Middleton D., Lowther S., Kelso A., Barr I.G. Multiple infections with seasonal influenza A virus induce cross-protective immunity against A(H1N1) pandemic influenza virus in a ferret model. J Infect Dis 2010, 202:1011-1020. 10.1086/656188.
27. Laurie K.L., Guarnaccia T.A., Carolan L.A., Yan A.W., Aban M., Petrie S., et al. Interval between infections and viral hierarchy are determinants of viral interference following influenza virus infection in a ferret model. J Infect Dis 2015, 1-10. 10.1093/infdis/jiv260.
28. Osterholm M.T., Kelley N.S., Sommer A., Belongia E.A. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2012, 12:36-44. 10.1016/S1473-3099(11)70295-X.
29. Kim J.H., Skountzou I., Compans R., Jacob J. Original antigenic sin responses to influenza viruses. J Immunol 2009, 183:3294-3301. 10.4049/jimmunol.0900398.
30. McLean H.Q., Thompson M.G., Sundaram M.E., Meece J.K., McClure D.L., Friedrich T.C., et al. Impact of repeated vaccination on vaccine effectiveness against influenza A(H3N2) and B during 8 seasons. Clin Infect Dis 2014, 59:1375-1385. 10.1093/cid/ciu680.
31. Linderman S.L., Chambers B.S., Zost S.J., Parkhouse K., Li Y., Herrmann C., et al. Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season. Proc Natl Acad Sci U S A 2014, 111:15798-15803. 10.1073/pnas.1409171111.
32. Treanor J., Kotloff K., Betts R., Belshe R., Newman F., Iacuzio D., et al. Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses. Vaccine 2000, 18:899-906.
33. Fox J.P., Cooney M.K., Hall C.E., Al E. Influenza virus infections in Seattle families, 1975-1979. Am J Epidemiol 1982, 116:228-242.